Paper39425166
Alternative splicing in ovarian cancer.
Wei L and 6 others. Cell Commun Signal, 2024. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Alternative splicing in ovarian cancer. Papers, record 39425166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39425166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ovarian Neoplasms | Major topic |
| Alternative Splicing | Major topic |
| Humans | |
| Female | |
| Animals |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 81971064 | National Natural Science Foundation of China | PubMed |
Source PubMed
References141
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28501461 | Spliceosome-associated factor CTNNBL1 promotes proliferation and invasion in ovarian cancer. | Exp Cell Res | 2017 | https://conductscience.org/library/papers/28501461 | PubMed |
| 2 | 32083075 | SF3b4: A Versatile Player in Eukaryotic Cells. | Front Cell Dev Biol | 2020 | https://conductscience.org/library/papers/32083075 | PubMed |
| 3 | 19371633 | Tumor suppressor KAI1 affects integrin alphavbeta3-mediated ovarian cancer cell adhesion, motility, and proliferation. | Exp Cell Res | 2009 | https://conductscience.org/library/papers/19371633 | PubMed |
| 4 | 29020823 | Platinum or nonplatinum in recurrent ovarian cancer: that is the question. | Future Oncol | 2017 | https://conductscience.org/library/papers/29020823 | PubMed |
| 5 | 35210412 | SF3B4 promotes ovarian cancer progression by regulating alternative splicing of RAD52. | Cell Death Dis | 2022 | https://conductscience.org/library/papers/35210412 | PubMed |
| 6 | 32332923 | Splicing factor proline- and glutamine-rich (SFPQ) protein regulates platinum response in ovarian cancer-modulating SRSF2 activity. | Oncogene | 2020 | https://conductscience.org/library/papers/32332923 | PubMed |
| 7 | 29130517 | Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem-like properties to ovarian cancer cells. | J Cell Biochem | 2018 | https://conductscience.org/library/papers/29130517 | PubMed |
| 8 | 12890739 | Emerging roles of BRCA1 alternative splicing. | Mol Pathol | 2003 | https://conductscience.org/library/papers/12890739 | PubMed |
| 9 | 27197267 | The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin. | Cancer Res | 2016 | https://conductscience.org/library/papers/27197267 | PubMed |
| 10 | 28488700 | Alternative splicing as a regulator of development and tissue identity. | Nat Rev Mol Cell Biol | 2017 | https://conductscience.org/library/papers/28488700 | PubMed |
| 11 | 7894493 | Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. | Nat Genet | 1994 | https://conductscience.org/library/papers/7894493 | PubMed |
| 12 | 18245464 | Multiple alternative splicing markers for ovarian cancer. | Cancer Res | 2008 | https://conductscience.org/library/papers/18245464 | PubMed |
| 13 | 9010228 | Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b. | Oncogene | 1997 | https://conductscience.org/library/papers/9010228 | PubMed |
| 14 | 22471593 | Architecture of the spliceosome. | Biochemistry | 2012 | https://conductscience.org/library/papers/22471593 | PubMed |
| 15 | 35343831 | Alternative Splicing: A New Therapeutic Target for Ovarian Cancer. | Technol Cancer Res Treat | 2022 | https://conductscience.org/library/papers/35343831 | PubMed |
| 16 | 26298390 | Invasion of ovarian cancer cells is induced byPITX2-mediated activation of TGF-β and Activin-A. | Mol Cancer | 2015 | https://conductscience.org/library/papers/26298390 | PubMed |
| 17 | 33623018 | Alternative splicing and cancer: a systematic review. | Signal Transduct Target Ther | 2021 | https://conductscience.org/library/papers/33623018 | PubMed |
| 18 | 19061484 | The SR protein family of splicing factors: master regulators of gene expression. | Biochem J | 2009 | https://conductscience.org/library/papers/19061484 | PubMed |
| 19 | 16190883 | PQBP-1 is expressed predominantly in the central nervous system during development. | Eur J Neurosci | 2005 | https://conductscience.org/library/papers/16190883 | PubMed |
| 20 | 30863109 | Extracellular matrix protein 1 (ECM1) is associated with carcinogenesis potential of human bladder cancer. | Onco Targets Ther | 2019 | https://conductscience.org/library/papers/30863109 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42640343 | Integrated genome-wide high-throughput screening and functional validation identifies Sm proteins as essential splicing regulators for gastric cancer progression. | Funct Integr Genomics | 2026 | https://conductscience.org/library/papers/42640343 | PubMed |
| 42633203 | LncRNA-driven alternative splicing landscapes associate with survival outcomes in ovarian cancer. | Noncoding RNA Res | 2026 | https://conductscience.org/library/papers/42633203 | PubMed |
| 42353343 | Comparative Analysis of Serum and Tissue miRNA Expression Profiles and Regulatory Pathways in Early-Stage Ovarian Cancer Using Public Databases. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353343 | PubMed |
| 42211461 | Integrated RNA-seq and sQTL analysis reveal immune and splicing regulatory features underlying relapse and remission after treatment of Graves' disease. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42211461 | PubMed |
| 42098443 | SNRPD2-CPSF7-UBE2K axis drives ovarian cancer progression via alternative splicing-polyadenylation crosstalk. | Oncogene | 2026 | https://conductscience.org/library/papers/42098443 | PubMed |
| 42046102 | Pharmacological targeting of SF3a1-MDM4 splicing vulnerability in ovarian cancer with rifaximin and antisense oligonucleotide. | J Transl Med | 2026 | https://conductscience.org/library/papers/42046102 | PubMed |
| 41833929 | Misregulated alternative splicing in endometriosis: a role for aberrant mRNA variants in endometriotic cell growth. | Cell Death Discov | 2026 | https://conductscience.org/library/papers/41833929 | PubMed |
| 41720762 | SNRPD2-mediated regulation of DDX39B splicing promotes endometrial cancer progression by suppressing the activation of CTSC cryptic exons. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41720762 | PubMed |
| 41452428 | The protective effect of probiotic therapy on gut microbiota and the activation of ω-oxidation after ovarian cancer surgery. | J Cancer Res Clin Oncol | 2025 | https://conductscience.org/library/papers/41452428 | PubMed |
| 41148455 | LRP11 as a potential predictor of poor prognosis and immune suppression in lung adenocarcinoma. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41148455 | PubMed |
| 40996600 | Extracellular matrix protein 1 in cancer: multifaceted roles in tumor progression, prognosis, and therapeutic targeting. | Arch Pharm Res | 2025 | https://conductscience.org/library/papers/40996600 | PubMed |
| 40837768 | Exploration of the association between SF3B4 and HMGB1 expression and the clinicopathological features and prognosis of gastric cancer. | World J Gastrointest Oncol | 2025 | https://conductscience.org/library/papers/40837768 | PubMed |
| 40579921 | PTBP1 and Cancer: From RNA Regulation to Therapeutic Potential. | J Cell Mol Med | 2025 | https://conductscience.org/library/papers/40579921 | PubMed |
| 40555777 | Spliceosomal GTPase EFTUD2 mediates DDX41 intron retention to promote the malignant progression of ovarian cancer. | Br J Cancer | 2025 | https://conductscience.org/library/papers/40555777 | PubMed |
| 39845971 | Alternative splicing of modulatory immune receptors in T lymphocytes: a newly identified and targetable mechanism for anticancer immunotherapy. | Front Immunol | 2024 | https://conductscience.org/library/papers/39845971 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BCL2L12 | 83596 | PubTator's text mining | https://conductscience.org/library/genes/83596 | NCBI Gene |
| BUD31 | 8896 | PubTator's text mining | https://conductscience.org/library/genes/8896 | NCBI Gene |
| CD44 | 960 | PubTator's text mining | https://conductscience.org/library/genes/960 | NCBI Gene |
| CD82 | 3732 | PubTator's text mining | https://conductscience.org/library/genes/3732 | NCBI Gene |
| CTNNBL1 | 56259 | PubTator's text mining | https://conductscience.org/library/genes/56259 | NCBI Gene |
| ECM1 | 1893 | PubTator's text mining | https://conductscience.org/library/genes/1893 | NCBI Gene |
| FLT3LG | 2323 | PubTator's text mining | https://conductscience.org/library/genes/2323 | NCBI Gene |
| PIGV | 55650 | PubTator's text mining | https://conductscience.org/library/genes/55650 | NCBI Gene |
| SF3B4 | 10262 | PubTator's text mining | https://conductscience.org/library/genes/10262 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39425166
GET https://conductscience.org/api/papers/v1/39425166/references?page=2